Signal transduction and oncogenesis by ErbB/HER receptors

Marmor, Mina D, Skaria, Kochupurakkal Bose, Yarden, Yosef·2004·International Journal of Radiation Oncology*Biology*Physics
DOI 10.1016/j.ijrobp.2003.06.002

Cited by (345)

Items 301–345 of 345

  1. Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines.
    Jin-Yu Xiang, Wen-Sheng Qiu, Xin-Gang Wang, F. Zhou, Zhen Wang, Shi-Hai Liu, L. Yue · 2013 · Oncology Report
  2. Mutational analysis of ErbB2 intracellular localization
    Li-Yong Chen, L. Qian, Zhiyi Zhang, M. Shi, Yu-Hua Song, Guogang Yuan, H. Zhang, Mei-Ru Hu, Ming Yu, Xue-Min Zhang et al. · 2007 · Histochemistry and Cell Biology
  3. Is EGFR expression altered following postoperative chemotherapy for colorectal adenocarcinoma?
    M. Khalifa, C. Rowsell, R. Gladdy, Y. Ko, S. Hanna, Andy Smith, C. Law · 2006 · World Journal of Surgical Oncology
  4. Nitration in cancer signaling
    Inge Claassen, Nirbachita Adrita, Kevin Brown Chandler, Stephen M. Black, Blaine R. Roberts, Álvaro G. Estévez, Joseph S. Beckman, María Clara Franco · 2026 · Redox Biology
  5. Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR
    Peiyuan Sun, Zhuoyi Wang, Ruohan Zhang, Xuanyou Li, Boxing Xu, Rui Shen, Jun Sheng, Jing Wang · 2025 · Scientific Reports
  6. Comprehensive bioinformatic analysis reveals a fibroblast-related gene signature for the diagnosis of keloids
    Yue Qi, GuiE Ma · 2024 · Heliyon
  7. Osteopontin expression and its relationship with prognostic biomarkers in canine mammary carcinomas
    L. Monteiro, B. Salgado, D. E. Oliveira, L. Rivera-Calderón, L. M. Montoya-Florez, Paula de Sanctis, N. Rocha · 2020 · Pesquisa Veterinária Brasileira
  8. Second-line therapy for advanced colorectal carcinoma
    Naureen Starling, David Cunningham · 2005 · Current Oncology Reports
  9. The resistance landscape of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer: molecular mechanisms and novel therapeutic strategies
    Shuotong Liu, Lin-Sen Zhou, Yongze He, Qianyi Liu, Ying Tang, Zhen Liu, Xianhu Zeng, Jiangping Li · 2026 · Translational Lung Cancer Research
  10. Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics
    Makito Motoyama, Ryota Shigefuku, Noriyoshi Tanaka, Mitsuaki Nishizawa, Keigo Oshio, Yoshitomo Suhara, Ichiro Yajima · 2025 · Anticancer Research
  11. A Preliminary Evaluation of the Prognostic Role of HER-2 and HER-3 Immunohistochemical Expression in Canine Melanomas
    F. Parisi, Luigi Aurisicchio, Arianna Pecorari, A. Poli, F. Millanta · 2024 · Animals
  12. Glucosylated Epigallocatechin Gallate (EGCG) Derivatives Combined with EGFR Tyrosine Kinase Inhibitor Overcome Resistance in EGFR T790M Mutant Lung Cancer
    Cheng‐Ting Zi · 2019 · Biomedical Journal of Scientific & Technical Research
  13. Quantification of EGFR family in canine mammary ductal carcinomas in situ: implications on the histological graduation
    E. Veloso, I. N. N. Gonçalves, Jaqueline Amorim Arantes, Rafael Vitor Santos de Abreu, G. Cassali, Ê. Ferreira · 2019 · Veterinary research communications
  14. Endometrial Cancer Treatment: New Insights into the Role of Erbb Receptors
    Georgios Androutsopoulos · 2016
  15. Optimization of the Protocol for the Isolation and Refolding of the Extracellular Domain of HER2 Expressed in Escherichia coli
    V. Dolgikh, I. Senderskiy, G. Tetz, V. Tetz · 2014 · Acta Naturae
  16. Resistance to HER2-Targeted Therapy in HER2+ Breast Cancer
    E. Kessler, A. Elias · 2012 · Clinical Medicine Reviews in Women s Health
  17. SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer
    Shu-Ping Hsueh, Wei-Bin Hsu, Chun-Chiang Wen, W.-B. Wang · 2011 · Cancer Gene Therapy
  18. Signal Transduction Inhibitors, HER Family, EGFR Inhibition and Clinical Achievements
    P. Zucali · 2007
  19. Somatic Genetic Development in Epithelial Ovarian Cancer
    Kate Lawrenson, Susan J. Ramus, Simon A. Gayther · 2009 · Springer eBooks
  20. Interaktionen von EGFR- und VEGFR-Inhibitoren mit Chirurgie und Strahlentherapie
    M. Krause, J. Fritzmann, P. Rodemann, M. Baumann · 2006 · Der Onkologe
  21. Nanoparticulate systems for combination therapies of lung cancer: A review
    Ayda Moradi, Sina Maskoukian, Tomasz Bączek, Navid Rabiee, Mohammad Reza Saeb, Mehdi Farokhi, Fatemeh Mottaghitalab · 2025 · Journal of Nanoparticle Research
  22. The expression of congenital Shoc2 variants induces AKT-dependent crosstalk activation of the ERK1/2 pathway
    Patricia G. Wilson, Lina G. Abdelmoti, Tianyan Gao, Emilia Galperin · 2024 · Human Molecular Genetics
  23. Early Application of Next-Generation Sequencing Identifies Pancreatic Mass as Metastasis From an EGFR-Mutated Lung Adenocarcinoma.
    Lu-Xi Chen, J. Davelaar, Srinivas Gaddam, K. Kosari, N. Nissen, G. Chaux, Christopher Lee, E. Vail, A. Hendifar, J. Gong et al. · 2022 · The Journal of the National Comprehensive Cancer Network
  24. Incomplete surgical resection of DCIS results in activation of HER-2 in residual breast cancer cells.
    C. Singer, G. Hudelist, E. Fuchs, W. Köstler, A. Fink-Retter, D. Gschwantler-Kaulich, M. Gnant, W. Lamm, M. Rudas, Ernst Kubista · 2009 · Journal of Clinical Oncology
  25. Untersuchung der subzellulären Lokalisation der Rezeptortyrosinkinase HER-3
    W. Schormann · 2008
  26. Differential Localization of ErbB Receptor Ensembles Influences Their Signaling in Hippocampal Neurons
    Jin-Qiu Chen, Henry C. Tseng, M. Dichter, H. Zhang, M. Greene · 2005 · DNA and Cell Biology
  27. EGFR Mutation and Tyrosine-Kinase Inhibitors (TKI) in Non Small Cell Lung Cancer: An Overview
    P. Gaur, Gaurav Singh, S. Bhattacharya, S. Kant, Sarika Pandey, R. Pandey, Pooja Singh · 2018
  28. Hydroxamic Acid Derivatives as Potential Anticancer Agents
    M. Gupta, Gagandip Singh, Swati Gupta · 2013 · Springer eBooks
  29. Human Epidermal Growth Factor Receptor 2 Dynamics Regulated by Actin-Filament Integrity on Cell Membranes Revealed by Single-Nanoconstruct Tracking.
    Xin Wen, Yuhao Leo Wu, Erik N Schaumann, Teri W. Odom · 2026 · ACS Nano
  30. The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation
    Katharina Gryksa, Maria Chiara Sibilia, Veit Rothhammer, Adrian Liston, Dietmar M. W. Zaiss · 2026 · Journal of Neuroinflammation
  31. The ErbB Receptors and Associated Key Signalling Proteins in Cancer
    I. Al-Janabi · 2026 · AL-Kindy College Medical Journal
  32. Pharmacophore Based Design and Development of Probable Multi Tyrosine Kinase Inhibitors from the 3D Crystal Structure of Gefitinib – A Drug Used in the Treatment of NSCLC
    Prangya Parimita Panda, A. Saha · 2026 · Research Journal of Pharmacy and Technology
  33. α, δ‑N‑Acetyl-glutamine Suppresses Neutrophilic Airway Inflammation by Activating the G Protein-Coupled Receptor/Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Phosphatase 1 Pathway.
    June-Mo Kim, Yu-Jin Choi, H. Chung, Yun-Jo Chung, Tae Hwan Kim, Kyoung-jin Jang, Chan-Mi Lee, Y. Kwon, Dong-Young Kang, S. Park et al. · 2025 · ACS Pharmacology & Translational Science
  34. Prey adopt similar adaptive strategies with different molecular response mechanisms: How do ciliates respond to different predation risk cues?
    Yumiao Zhou, Chai Li, Weihuang Chen, Xiaofeng Lin, Ji-Qiu Li · 2025 · Water Biology and Security
  35. The expression of congenital Shoc2 variants induces AKT-dependent feedback activation of the ERK1/2 pathway
    Patricia G. Wilson, Lina G. Abdelmoti, Tianyan Gao, Emilia Galperin · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Understanding the Biology Behind the EGFR to Improve NSCLC Patients’ Treatment
    Alberto Verlicchi, Alfredo Addeo · 2017 · Journal of Molecular and Genetic Medicine
  37. Note on Three Classes of Data Grid Operations
    Arcot Rajasekar, Hao Xu, Reagan Moore · 2014 · Journal of Computer and Communications
  38. Signal Transduction Inhibitors of the HER Family
    Christina E. Brzezniak, Corey Allan Carter, Anish Thomas, Giuseppe Giaccone · 2013 · CRC Press eBooks
  39. Identification of the tumour-associated gene S100A14 and analysis of its regulation
    Agnieszka Piętas · 2005
  40. Design, Synthese und massenspektrometrische Analyse kovalenter und kovalent-reversibler Kinaseinhibitoren
    S. Smith · 2017
  41. Brain Metastasis of Patients with Lung Adenocarcinoma: Epidermal Growth Factor Receptor Mutations and Response to Whole-Brain Radiation Therapy
    Shang-Gin Wu, J. Shih · 2014
  42. The prognostic potential of the epidermal growth factor receptor and nuclear factor kappa B pathways and associated therapeutic strategies in patients with squamous cell carcinoma of the head and neck
    P. Wirth · 2010
  43. Studies on Memo, an important ErbB2 receptor-mediated component of the cellular migratory machinery
    Maria Meira · 2009 · edoc (University of Basel)
  44. The Advancement of Epidermal Growth Factor Receptor Inhibitors in Cancer Therapy
    G. Allen, P. Harari · 2007
  45. Current and Future Therapeutic Targets of the Tumour-Host Microenvironment
    J. Kassis, E. Alejandro, Victoria M. Virador, E. Kohn · 2005 · Springer eBooks